Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/25 06:02 | 3/4/25 | WRBY | Health | OthMd | Ophthalmic Goods | Miller Steven Clive | NY | O | CFO | 2 | M.d | 275 | 6.97 | 0 | 39 | 24 | 205 | D | ||||||||||||||
3/6/25 06:02 | 3/4/25 | WRBY | Health | OthMd | Ophthalmic Goods | Miller Steven Clive | NY | O | CFO | 2 | S.d | -275 | 6.97 | 0 | -39 | 205 | D | |||||||||||||||
3/5/25 21:57 | 3/4/25 | WRBY | Health | OthMd | Ophthalmic Goods | Gilboa David Abraham | NY | DO | Co-CEO | 5 | M.dm | 19,231 | 24.62 | 0 | 781 | 24 | D | |||||||||||||||
3/5/25 21:57 | 3/4/25 | WRBY | Health | OthMd | Ophthalmic Goods | Gilboa David Abraham | NY | DO | Co-CEO | 5 | S.dm | -19,231 | 24.62 | 0 | -781 | 24 | D | |||||||||||||||
3/5/25 21:56 | 3/3/25 | WRBY | Health | OthMd | Ophthalmic Goods | Blumenthal Neil Harris | NY | DO | Co-CEO | 6 | S.dm | -17,003 | 24.96 | 0 | -681 | 424 | D | |||||||||||||||
3/5/25 21:56 | 3/4/25 | WRBY | Health | OthMd | Ophthalmic Goods | Blumenthal Neil Harris | NY | DO | Co-CEO | 6 | M.dm | 17,003 | 24.96 | 0 | 681 | 424 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |